High Performance UHPLC System Gets More Out of Every Sample
A new ultra high-performance liquid chromatography (UHPLC) system delivers exceptional performance and reliable separations with the flexibility required for labs developing methods ranging from high-throughput analyses to pharmaceutical quality control applications.
As the latest addition to the Thermo Scientific Vanquish product family, the Thermo Scientific Vanquish Flex UHPLC system is designed for high speed, resolution and sensitivity, allowing users to perform biocompatible analysis to obtain high quality and consistent data. By incorporating an integrated modular design, customers have the ability to mix and match modules depending on the demands of the application.
“Throughout the biopharmaceutical workflow, data integrity is essential to ensure decisions can be made from drug discovery and development to batch release in quality control,” said Fraser McLeod, vice president and general manager, HPLC for Thermo Fisher Scientific. “To achieve confidence and speed in results, sensitivity and throughput are crucial. We have developed a system that showcases high resolution separation and reproducibility for advanced analyses for a range of liquid chromatography applications.”
The Vanquish Flex system is designed to provide sharp peaks at high throughputs, allowing more data to be analysed in less time. Data quality is ensured via the robustness and repeatability of the system to ensure that large sample sets can be analysed for comparison during QC protocols. Key features include:
• A new quaternary gradient pump module, designed for robustness without compromising performance, which provides method development flexibility while increasing throughput.
• Excellent performance operating at 1000 bar maximum pump pressure, with flow rates of up to 8 mL/min to allow for high-resolution separations and application flexibility.
• New fluorescence detector for increased sensitivity complements the absorbance detector module for high sensitivity and extended linearity and the new charged aerosol detector module for non-volatile compounds.
HPLC analysis requires more than just hardware. To complement the new Vanquish Flex system, the new Thermo Scientific SMART Digest kit is a new protein digestion tool that provides sensitive and fast analyses. In addition, the Thermo Scientific AppsLab library of analytical applications, the fully searchable online method repository offers protocols, method information, chromatograms and all the information to run, process and report an analysis.
Related News
-
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Pharma Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain. -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
News BIOSECURE Act continues to loom over Chinese pharma manufacturers
With the US BIOSECURE Act on its way to passing into legislation, Chinese companies are facing declining revenues within the first half of 2024 as US pharmaceutical and healthcare companies pull their businesses from the country. -
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance